{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:18:00Z","timestamp":1790713080616,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11255-022-03156-x","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T04:02:52Z","timestamp":1649476972000},"page":"1233-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term outcomes of whole gland high-intensity focused ultrasound for localized prostate cancer"],"prefix":"10.1007","volume":"54","author":[{"given":"Kevin","family":"Lo Verde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Bastide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6935-3873","authenticated-orcid":false,"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"5","key":"3156_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"15","key":"3156_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415\u20131424","journal-title":"N Engl J Med"},{"issue":"12","key":"3156_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1056\/NEJMoa074311","volume":"358","author":"MG Sanda","year":"2008","unstructured":"Sanda MG, Dunn RL, Michalski J et al (2008) Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358(12):1250\u20131261","journal-title":"N Engl J Med"},{"issue":"21","key":"3156_CR4","first-page":"01949","volume":"S0302\u20132838","author":"JS Hopstaken","year":"2021","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, F\u00fctterer JJ, Rovers MM (2021) An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years? Eur Urol S0302\u20132838(21):01949\u201301957","journal-title":"Eur Urol"},{"issue":"1","key":"3156_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE et al (2017) New and established technology in focal ablation of the prostate: a systematic review. Eur Urol 71(1):17\u201334","journal-title":"Eur Urol"},{"issue":"9","key":"3156_CR6","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1464-410X.2012.11262.x","volume":"110","author":"ER Cordeiro","year":"2012","unstructured":"Cordeiro ER, Cathelineau X, Thuroff S, Marberger M, Crouzet S, de la Rosette JJ (2012) High intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer. BJU Int 110(9):1228\u20131242","journal-title":"BJU Int"},{"issue":"2","key":"3156_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.prnil.2019.12.002","volume":"8","author":"PL Royce","year":"2020","unstructured":"Royce PL, Ooi JJY, Sothilingam S, Yao HH (2020) Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer. Prostate Int 8(2):85\u201390","journal-title":"Prostate Int"},{"issue":"2","key":"3156_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E et al (2021) Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79(2):243\u2013262","journal-title":"Eur Urol"},{"issue":"3","key":"3156_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","volume":"199","author":"MG Sanda","year":"2018","unstructured":"Sanda MG, Cadeddu JA, Kirkby E et al (2018) Clinically localized prostate cancer: AUA\/ASTRO\/SUO Guideline. Part I: risk stratification, shared decision making, and care options. J Urol 199(3):683\u2013690","journal-title":"J Urol"},{"issue":"4","key":"3156_CR10","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach M 3rd, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4):965\u2013974","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3156_CR11","first-page":"518","volume":"111","author":"PA Clavien","year":"1992","unstructured":"Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111(5):518\u2013526","journal-title":"Surgery"},{"key":"3156_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","volume":"65","author":"S Crouzet","year":"2014","unstructured":"Crouzet S, Chapelon JY, Rouvi\u00e8re O et al (2014) Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol 65:907\u2013914","journal-title":"Eur Urol"},{"key":"3156_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.juro.2014.07.096","volume":"193","author":"T Uchida","year":"2015","unstructured":"Uchida T, Tomonaga T, Kim H et al (2015) Improved outcomes with advancements in high intensity focused ultrasound devices for the treatment of localized prostate cancer. J Urol 193:103\u2013110","journal-title":"J Urol"},{"issue":"10","key":"3156_CR14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00345-018-2613-z","volume":"37","author":"B Rosenhammer","year":"2019","unstructured":"Rosenhammer B, Ganzer R, Zeman F, N\u00e4ger T, Fritsche HM, Blana A, Burger M, Br\u00fcndl J (2019) Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis. World J Urol 37(10):2073\u20132080","journal-title":"World J Urol"},{"key":"3156_CR15","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1155\/2014\/186782","volume":"2014","author":"K Limani","year":"2014","unstructured":"Limani K, Aoun F, Holz S, Paesmans M, Peltier A, van Velthoven R (2014) Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes. Prostate Cancer 2014:1782","journal-title":"Prostate Cancer"},{"issue":"3","key":"3156_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1464-410X.2012.11715.x","volume":"112","author":"R Ganzer","year":"2013","unstructured":"Ganzer R, Fritsche HM, Brandtner A, Br\u00fcndl J, Koch D, Wieland WF, Blana A (2013) Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer. BJU Int 112(3):322\u2013329","journal-title":"BJU Int"},{"key":"3156_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.12.016","author":"J Br\u00fcndl","year":"2021","unstructured":"Br\u00fcndl J, Osberghaus V, Zeman F, Breyer J, Ganzer R, Blana A, Gierth M, Denzinger S, Burger M, Rosenhammer B (2021) Oncological long-term outcome after whole-gland high-intensity focused ultrasound for prostate cancer-21-yr follow-up. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2020.12.016","journal-title":"Eur Urol Focus"},{"issue":"4","key":"3156_CR18","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.eururo.2016.02.054","volume":"70","author":"L Dickinson","year":"2016","unstructured":"Dickinson L, Arya M, Afzal N et al (2016) Medium-term outcomes after whole-gland high-intensity focused ultrasound for the treatment of nonmetastatic prostate cancer from a multicentre registry cohort. Eur Urol 70(4):668\u2013674","journal-title":"Eur Urol"},{"issue":"6","key":"3156_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/iju.13581","volume":"25","author":"PY Chen","year":"2018","unstructured":"Chen PY, Chiang PH, Liu YY, Chuang YC, Cheng YT (2018) Primary whole-gland ablation for localized prostate cancer with high-intensity focused ultrasound: the important predictors of biochemical recurrence. Int J Urol 25(6):615\u2013620","journal-title":"Int J Urol"},{"issue":"1","key":"3156_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/02656736.2021.1945150","volume":"38","author":"S Shoji","year":"2021","unstructured":"Shoji S, Uchida T, Hanada I et al (2021) Analysis of oncological outcomes of whole-gland therapy with high-intensity focused ultrasound for localized prostate cancer in clinical and technical aspects: a retrospective consecutive case-series analysis with a median 5-year follow-up. Int J Hyperth 38(1):1205\u20131216","journal-title":"Int J Hyperth"},{"issue":"7","key":"3156_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236026","volume":"15","author":"YT Wu","year":"2020","unstructured":"Wu YT, Chiang PH (2020) Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: medium-term results from a single centre. PLoS ONE 15(7):e0236026","journal-title":"PLoS ONE"},{"issue":"2","key":"3156_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.euf.2019.11.014","volume":"7","author":"A Dosanjh","year":"2021","unstructured":"Dosanjh A, Harvey P, Baldwin S et al (2021) High-intensity focused ultrasound for the treatment of prostate cancer: a national cohort study focusing on the development of stricture and fistulae. Eur Urol Focus 7(2):340\u2013346","journal-title":"Eur Urol Focus"},{"issue":"49","key":"3156_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19490","volume":"19","author":"CR Ramsay","year":"2015","unstructured":"Ramsay CR, Adewuyi TE, Gray J et al (2015) Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess 19(49):1\u2013490","journal-title":"Health Technol Assess"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-022-03156-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03156-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:20:20Z","timestamp":1652091620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-022-03156-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3156"],"URL":"https:\/\/doi.org\/10.1007\/s11255-022-03156-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}